Angela N Duke1, Matthew W Johnson1, Chad J Reissig1, Roland R Griffiths2,3. 1. Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, 5510 Nathan Shock Drive, Baltimore, MD, 21224-6823, USA. 2. Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, 5510 Nathan Shock Drive, Baltimore, MD, 21224-6823, USA. rgriff@jhmi.edu. 3. Department of Neuroscience, Johns Hopkins University School of Medicine, 5510 Nathan Shock Drive, Baltimore, MD, 21224-6823, USA. rgriff@jhmi.edu.
Abstract
RATIONALE: Global tobacco-related mortality dwarfs that of all other drugs. Nicotine is believed to be the primary agent responsible for tobacco use and addiction. However, nicotine is a relatively weak and inconsistent reinforcer in nonhumans and nicotine reinforcement has not been demonstrated in never-smokers. OBJECTIVES: This study investigated the discriminative, subjective, and reinforcing effects of nicotine in never-smokers. METHODS:Eighteen never-smokers (< 50 lifetime nicotine exposures) participated in a double-blind study. During a drug discrimination phase, volunteers ingested oral nicotine and placebo capsules (quasi-random order) at least 2 h apart and rated subjective effects repeatedly for 2 h after ingestion in daily sessions. Blocks of 10 sessions were continued until significant discrimination was achieved (p ≤ 0.05, binomial test; ≥ 8 of 10). Following discrimination, nicotine choice was tested by having volunteers choose which capsule set to ingest on each daily session. Successive blocks of 10 sessions were conducted until choice for nicotine or placebo met significance within each volunteer (≥ 8 of 10 sessions). RESULTS: All 18 volunteers significantly discriminated nicotine from placebo; the lowest dose discriminated ranged from 1.0 to 4.0 mg/70 kg. Nine volunteers significantly chose nicotine (choosers) and nine significantly chose placebo (nicotine avoiders). The choosers reported predominately positive nicotine subjective effects (e.g., alert/attentive, good effects, liking), while avoiders tended to report negative effects (e.g., dizzy, upset stomach, disliking). Both choosers and avoiders attributed their choice to the qualitative nature of drug effects. CONCLUSIONS: These results provide the first evidence that nicotine can function as a reinforcer in some never-smokers.
RCT Entities:
RATIONALE: Global tobacco-related mortality dwarfs that of all other drugs. Nicotine is believed to be the primary agent responsible for tobacco use and addiction. However, nicotine is a relatively weak and inconsistent reinforcer in nonhumans and nicotine reinforcement has not been demonstrated in never-smokers. OBJECTIVES: This study investigated the discriminative, subjective, and reinforcing effects of nicotine in never-smokers. METHODS: Eighteen never-smokers (< 50 lifetime nicotine exposures) participated in a double-blind study. During a drug discrimination phase, volunteers ingested oral nicotine and placebo capsules (quasi-random order) at least 2 h apart and rated subjective effects repeatedly for 2 h after ingestion in daily sessions. Blocks of 10 sessions were continued until significant discrimination was achieved (p ≤ 0.05, binomial test; ≥ 8 of 10). Following discrimination, nicotine choice was tested by having volunteers choose which capsule set to ingest on each daily session. Successive blocks of 10 sessions were conducted until choice for nicotine or placebo met significance within each volunteer (≥ 8 of 10 sessions). RESULTS: All 18 volunteers significantly discriminated nicotine from placebo; the lowest dose discriminated ranged from 1.0 to 4.0 mg/70 kg. Nine volunteers significantly chose nicotine (choosers) and nine significantly chose placebo (nicotine avoiders). The choosers reported predominately positive nicotine subjective effects (e.g., alert/attentive, good effects, liking), while avoiders tended to report negative effects (e.g., dizzy, upset stomach, disliking). Both choosers and avoiders attributed their choice to the qualitative nature of drug effects. CONCLUSIONS: These results provide the first evidence that nicotine can function as a reinforcer in some never-smokers.
Entities:
Keywords:
Drug discrimination; Never-smoker; Nicotine; Oral; Reinforcement; Self-administration; Subjective effects
Authors: Kenneth A Perkins; Nicole Kunkle; Joshua L Karelitz; K A Perkins; N Kunkle; J L Karelitz Journal: Drug Alcohol Depend Date: 2017-03-23 Impact factor: 4.492
Authors: John R Hughes; Erica N Peters; Peter W Callas; Catherine Peasley-Miklus; Emmanuel Oga; Jean-Francois Etter; Nicholas Morley Journal: Nicotine Tob Res Date: 2020-04-21 Impact factor: 4.244
Authors: Kenneth A Perkins; Nicole Kunkle; Valerie C Michael; Joshua L Karelitz; Eric C Donny Journal: Nicotine Tob Res Date: 2016-03-24 Impact factor: 4.244
Authors: Kenneth A Perkins; Nicole Kunkle; Joshua L Karelitz; Valerie C Michael; Eric C Donny Journal: Psychopharmacology (Berl) Date: 2016-04-02 Impact factor: 4.530